FLT3 and acute myeloid leukemia: To reflect the increasing interest within clinical and basic research, we aimed to systematically review the current body of literature and to synthesize the existing evidence regarding the outcome of TKI maintenance therapy after allogeneic stem-cell transplantation for patients with FLT3-ITD-mutated AML.